Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2011-05-27

Clinical Trial Update: Optic Nerve and Retinal Functions With Bevacizumab

View source ↗

Summary

This trial update reports on optic nerve and retinal function outcomes in eyes with choroidal neovascularization treated with bevacizumab.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Bevacizumab (Avastin) (bevacizumab)

Snippet

Sponsor: Cairo University | Conditions: Choroidal Neovascular Membrane | Status: COMPLETED